HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats.

Abstract
We studied the IGFBP-3 response to endotoxin, in Wistar and Lewis rats. Compared to Wistar rats, Lewis rats have a reduced adrenal and IGF-I response to inflammatory stimuli. Rats received two injections of 1 mg/kg of lipopolysaccharide (LPS) and were killed 4 h after the second injection. LPS decreased serum concentrations of GH in Wistar (P<0.05), but not in Lewis rats. However, serum IGFBP-3 was decreased both in Wistar and in Lewis rats. Furthermore, LPS administration decreased IGFBP-3 gene expression in the liver in both rat strains (P<0.01). Lewis rats had lower serum IGFBP-3 than Wistar rats (P<0.01). This difference could be secondary to the increased IGFBP-3 proteolysis in serum observed in Lewis rats. These data indicate that acute inflammation inhibits serum concentrations of IGFBP-3 by decreasing its synthesis in the liver, rather than increasing its proteolysis. This effect seems to be GH and IGF-I independent.
AuthorsT Priego, I Ibáñez de Cáceres, A I Martín, M A Villanúa, A López-Calderón
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 199 Issue 1-2 Pg. 23-8 (Jan 31 2003) ISSN: 0303-7207 [Print] Ireland
PMID12581876 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin-Like Growth Factor Binding Protein 3
  • Lipopolysaccharides
  • RNA, Messenger
  • Endopeptidases
Topics
  • Animals
  • Endopeptidases (metabolism)
  • Inflammation (blood)
  • Insulin-Like Growth Factor Binding Protein 3 (biosynthesis, blood, drug effects)
  • Lipopolysaccharides (pharmacology)
  • Liver (metabolism)
  • Male
  • RNA, Messenger (biosynthesis, drug effects)
  • Rats
  • Rats, Inbred Lew (metabolism)
  • Rats, Wistar (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: